NCT01163175

Brief Summary

The majority of trans fatty acids consumed by the general population is derived from products that have been formulated using significant amount of hydrogenated vegetable oil (the so-called industrial trans fat). Fat from ruminants also contains small amounts of trans fatty acid, which contribute, although to a smaller extent, to the total dietary intake of trans fatty acids in the general population. The negative impact of consuming industrial trans fat on health, particularly on cardiovascular disease, is being increasingly recognized. Based on data available to date, it is currently not possible to conclude if effects of ruminants and industrial trans fatty acid on cardiovascular risk are different. There is therefore an urgent need for a study that compares the impact of naturally occurring trans fatty acids such as those from dairy products and of trans fatty acids form industrial sources on cardiovascular risk factors as well as their mechanisms of action. The general objective of the study is to investigate the impact of naturally occurring trans fatty acids from dairy products (mainly vaccenic acid) on plasma cholesterol levels and other risk factors for cardiovascular disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2006

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

July 9, 2010

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 15, 2010

Completed
Last Updated

February 11, 2011

Status Verified

July 1, 2010

Enrollment Period

1.2 years

First QC Date

July 9, 2010

Last Update Submit

February 10, 2011

Conditions

Keywords

Cardiovascular diseaseTrans fatty acidsRuminantBlood lipids

Outcome Measures

Primary Outcomes (1)

  • Plasma LDL-Cholesterol concentrations

    At the beginning and the end of the 4 for-week diets

Secondary Outcomes (5)

  • Blood lipids and apolipoproteins levels (Total cholesterol, HDL-Cholesterol, Triglycerides, Apo A1, Apo B)

    At the beginning and the end of the 4 for-week diets

  • Markers of inflammation (C-reactive protein)

    At the beginning and the end of the 4 for-week diets

  • Blood pressure

    At the beginning and the end of the 4 for-week diets

  • Anthropometric measures (waist and hip circumferences)

    At the beginning and the end of the 4 for-week diets

  • Surrogates of cholesterol absorption and synthesis

    At the beginning and the end of the 4 for-week diet

Interventions

Consumption of the 4 experimental diets: 1. a diet rich in ruminant TFA (8 g/day); 2. a diet moderately rich in ruminant TFA (4 g/day); 3. a diet rich in industrial TFA (8 g/d); 4. a control diet (minimal dietary TFA of industrial and ruminant sources).

Eligibility Criteria

Age18 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men
  • LDL-Cholesterol concentration \<3.4 mmol/L
  • Stable body weight (+/- 2 kg) for 6 months before the beginning of the study
  • Smoking or not

You may not qualify if:

  • Previous history of cardiovascular disease, type 2 diabetes and monogenic dyslipidemia
  • Subjects taking medications for hyperlipidemia or hypertension
  • Endocrine disorders
  • Body mass index \> 30 kg/m2
  • Food allergies
  • Men with extreme nutritional habits such as vegetarism or alcohol consumption \> 2 drinks/day
  • Elite athletes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Nutraceutical and Functional Foods (INAF), Laval University

Québec, Quebec, G1V 0A6, Canada

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Benoît Lamarche, PhD

    Laval University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 9, 2010

First Posted

July 15, 2010

Study Start

May 1, 2006

Primary Completion

July 1, 2007

Study Completion

November 1, 2007

Last Updated

February 11, 2011

Record last verified: 2010-07

Locations